Navigation Links
La Jolla Institute discovers novel mechanism for preventing infection via body's mucosal borders
Date:10/3/2011

dged by the robust memory T cell response they induce in the blood and lymph nodes. "We judge vaccines on the strength of proliferation of systemic memory T cells," she said. "But this doesn't necessarily mean we are generating protective immunity in the intestines or at other mucosal borders."

She said the reason vaccines are measured this way is logistical. "Researchers can easily take a blood sample and measure T cell numbers in an individual's blood," she said. "However, we cannot, as a practical matter, measure T cells in the intestines of a living person. So although many vaccines induce effective immune protection, we don't know whether a particular vaccine protects us from viruses and bacteria entering through the mucosal linings because up until now, we didn't have a way to measure pre-existing immunity at mucosal interfaces."

The team found a remedy for that situation by showing that the induction of CD8aa on the immune cells in the blood activated by the vaccine warrants protection at the mucosal borders. "This gives us a means of testing potential vaccines for their protective ability at mucosal borders such as the intestine and other pathogen entry-sites," she said. "Basically, the more CD8aa positive immune effector T cells that are generated by a vaccine, the better the protection at mucosal borders."

Dr. Cheroutre noted that her finding provides information about the mechanism of action for generating mucosal T cell memory, but it remains to be determined how vaccines can be engineered to induce this valuable mucosal immune memory. "This will be the next step for us and for the broader research community," she said. "To provide an effective vaccine, we need to be able to trigger the body to do what the endogenous immune system is doing induce high affinity effector T cells and selectively sort out those cells to reside at the mucosal borders."

The finding represents Dr. Cheroutre's second major discovery o
'/>"/>

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. La Jolla Institute discovers previously unknown cell interaction key in immune system attacks
2. La Jolla Institute opens major RNAi center for identifying genetic triggers of disease
3. La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders
4. La Jolla Institute-led team illuminates cell pathway key to insulin resistance in Type 2 diabetes
5. La Jolla Institute validates Type 1 diabetes computer models predictive success through lab testing
6. La Jolla Institute scientist Klaus Ley receives Malpighi award
7. La Jolla Institute scientist leads team which discovers important new player in diabetes onset
8. Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
9. La Jolla Institute discovers novel tumor suppressor
10. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
11. Institute for Genomic Biology, School of Integrative Biology receive major NSF training grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2015)... , March 24, 2015   Crossmatch ... solutions, today announced that its U.are.U ® ... retailer Goorin Bros . to achieve PCI ... solution secures access to the POS terminal, protecting ... risk of data breaches. With ...
(Date:3/23/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces its biometric payment technology, the Wocket® smart ... starting March 30 th . The ... New York markets. Gino ... our new ad campaign following the recent initial shipment of ...
(Date:3/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) ... Global Strategic Business Report" report to their offering. ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... Latin America . Annual estimates and ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... 12 Orchid Cellmark Inc.,(Nasdaq: ORCH ) today ... of Orchid, is scheduled to present at the 2008 ... Wednesday, May 14, 2008 at,3:20 p.m. PDT., Mr. ... the,company,s recent and ongoing progress. A link to the ...
... most attractive male birds attract more females and as a ... the starting point of many studies looking for factors that ... assume that birds see what we see? In a study ... show that our human vision is not an adequate instrument. ...
... taken two unlikely distant cousins turkeys and scallops - ... University of Leeds researchers have found that a motor protein, ... , The discovery suggests that the tiny motor protein ... humans it may even hold a key to understanding potentially ...
Cached Biology News:Human vision inadequate for research on bird vision 2Ancient protein offers clues to killer condition 2
(Date:5/4/2015)... - New Massive Open Online Course (MOOC) ... United States Medical Licensing Examination Elsevier ... information products and services, announced today that it has ... to help medical students prepare for the United States ... most daunting of the three exams medical students must ...
(Date:5/1/2015)...  Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW Bio"), ... for solid tumor cancers, announced today that the Company ... a $40 million investment from Woodford investment funds in ... million in NW Bio on November 19, 2014.  On ... the Company for a further $40 million investment in ...
(Date:5/1/2015)... A new report by  visiongain ... reach $22.4bn in 2019. That revenue forecast and others ... Prospects 2015-2025 ,  published in March 2015. ... provide forecasts and qualitative analyses of the antithrombotic drugs ... in London, UK . It produces ...
(Date:4/30/2015)... Carolina (PRWEB) May 01, 2015 Spirax ... services, is extremely proud to announce that for the ... named as a winner of a Queen’s Award for ... for the design and manufacture of a unique flowmeter. ... the revolutionary alternative to traditional steam flow measurement. ...
Breaking Biology Technology:Elsevier's Free MOOC Prepares Med Students for Licensing Exam 2Elsevier's Free MOOC Prepares Med Students for Licensing Exam 3NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3
... to $245 Million to $247 Million -, Third Quarter 2008 Highlights:, ... quarter of 2007 -- Total revenues without Osteocel of $62.5 million; ... -- Gross profit of $54.7 million; up 73.2% from the ... to 82.0% in the third quarter of 2007, -- GAAP ...
... Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) today announced that ... on Wednesday, October 29,2008, after the market closes. The ... 5:00 p.m. ET, which will be open to the ... company will review,the financial results and discuss other business ...
... Oct. 22 MaxCyte, Inc., the pioneer,in scalable, ... will,be launching the MaxCyte STX Scalable Transfection System ... Based Assays: Innovations,in Reagents, Technology, and Screening," to ... and Friday, October 23-24, 2008. In addition, MaxCyte ...
Cached Biology Technology:Nuvasive Reports Third Quarter 2008 Financial Results 2Nuvasive Reports Third Quarter 2008 Financial Results 3Nuvasive Reports Third Quarter 2008 Financial Results 4Nuvasive Reports Third Quarter 2008 Financial Results 5Nuvasive Reports Third Quarter 2008 Financial Results 6Nuvasive Reports Third Quarter 2008 Financial Results 7Nuvasive Reports Third Quarter 2008 Financial Results 8Nuvasive Reports Third Quarter 2008 Financial Results 9Nuvasive Reports Third Quarter 2008 Financial Results 10Nuvasive Reports Third Quarter 2008 Financial Results 11Nuvasive Reports Third Quarter 2008 Financial Results 12Sangamo BioSciences Announces Third Quarter Conference Call and Webcast 2Sangamo BioSciences Announces Third Quarter Conference Call and Webcast 3The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays 2
... Channel Cell Lines ,High Quality, Functionally-Validated, Ion ... well known for having a critical role ... have a key function in pain, CNS ... channels have been investigated in therapeutic areas, ...
Mouse monoclonal antibody raised against a partial recombinant TTC3. NCBI Entrez Gene ID = TTC3...
Mouse polyclonal antibody raised against a partial recombinant SYT4. NCBI Entrez Gene ID = 6860...
Mouse monoclonal antibody raised against a partial recombinant IL31RA. NCBI Entrez Gene ID = IL31RA...
Biology Products: